American Society of Hematology

Meet the Trainee Council

Fellows are invited to apply for a position on the Trainee Council. Trainees who exhibit leadership qualities and a high potential for a successful career in hematology or a hematology-related discipline are desired candidates.

Second-Year Council Members

Council Chair - Leidy Isenalumhe, MD, MS


Leidy Isenalumhe, MD,

Dr. Isenalumhe is double trained in pediatric and adult hematology oncology. She is currently continuing her training at Moffitt Cancer Center in Tampa, Florida after completing her Pediatric fellowship at Children’s Hospital Los Angeles. Her research and career goals are to focus on the Adolescent and Young Adult oncology population with focus on toxicities and other disparities.


Hanny Al-Samkari, MD


Hanny Al-Samkari, MD

Dr. Al-Samkari is a senior clinical hematology/oncology fellow at the Dana-Farber Cancer Institute/Massachusetts General Hospital Partners program in Boston. He has strong interests in classical, non-malignant hematology (especially thrombosis and hemostasis), medical education, and clinical research. He currently investigates novel uses for thrombopoiesis-stimulating agents and is doing work in malignancy-associated thrombosis. As a member of the trainee council, he has been very involved in educational programs and ASH trainee publications.


Shruti Bhatt, PhD


Shruti Bhatt, PhD

Dr. Bhatt is a postdoctoral fellow at Dana-Farber Cancer institute in Boston. She completed her PhD from the University of Miami. Her current research focuses on identifying personalized therapy for leukemia patients using a novel technology, BH3 profiling. As a part of the ASH Trainee Council she has been involved in improving resources and programs for the development of early career scientists.

Ang Li, MD


Ang Li, MD

Dr. Li is a senior fellow in hematology/oncology at the University of Washington and Fred Hutchinson Cancer Research Center (FHCRC) in Seattle. He was previously a Fulbright research scholar in Spain and an American Society of Hematology (ASH) HONORS research grant recipient. His current research interests include the prevention and treatment of venous thrombosis and thrombotic microangiopathy in patients with hematologic malignancy and hematopoietic cell transplantation.

Scott Moerdler, MD


Scott Moerdler, MD

Dr. Moerdler is a second-year fellow in pediatric hematology/oncology at the Children’s Hospital at Montefiore in New York. He is currently working in an Immunology lab on novel immune-checkpoints for cancer treatment. He also has a strong interest in medical education.


Deva Sharma, MD


Deva Sharma, MD

Dr. Sharma is a third year hematology-oncology fellow at Vanderbilt University. She is studying reproductive health challenges in women with sickle cell disease and is the recipient of the Foundation for Women and Girls with Blood Disorders Research Award. She has enrolled in a transfusion medicine fellowship at Vanderbilt, which will begin after completion of her hematology-oncology fellowship. She joined the ASH Trainee Council to make a meaningful impact on hematology training experiences during fellowship, particularly for those interested in non-malignant hematology. Outside of medicine, her interests include traveling, music and learning new languages.

back to top

First-Year Council Members

Puja Arora, MD


Puja Arora, MD

Dr. Arora graduated from Wright State University Boonshoft School of Medicine and completed her internal medicine residency at Washington Hospital Center in Washington, D.C. She is currently a second year hematology/oncology fellow at the University of Virginia in Charlottesville, VA. She is interested in pursuing a career in hematological malignancies.

Alexander Boucher, MD


Alexander Boucher, MD

Dr. Boucher graduated from the University of Tennessee College of Medicine and completed his combined internal medicine and pediatrics residency at the University of Minnesota. He is currently a second year pediatric hematology and oncology fellow at Cincinnati Children's Hospital Medical Center. His clinical and lab-based research interests are both focused on hemostasis and thrombosis with solid organ transplants.

Jaime Gastwirt, MD


Jaime Gastwirt, MD

Dr. Gastwirt’s journey to hematology began with a curiosity and love for science during her undergraduate career at Vanderbilt University. After many years of bench research within the pharmaceutical industry, Dr. Gastwirt began her medical and military career at the Uniformed Services University F. Edward Hébert School of Medicine. She is currently an active duty U.S. Naval officer serving at Walter Reed National Military Medical Center in Bethesda, MD while completing her fellowship in hematology and oncology.

Surbhi Sidana, MBBS


Surbhi Sidana, MD

Dr. Sidana graduated from Maulana Azad Medical College of the University of Delhi, India and completed residency training in internal medicine at Cleveland Clinic in Cleveland, Ohio. Dr. Sidana is a hematology and oncology fellow at Mayo Clinic in Rochester, Minnesota. Her research interests include plasma cell disorders and patient reported outcomes.

Arun K. Singavi, MD


Arun Singavi, MD

Dr. Singavi completed a dual bachelor’s in Business Management and Biology at the University of Illinois-Chicago, medical school at St. George's University, internal medicine residency at Medical College of Wisconsin, and served as a Chief Resident prior to fellowship. He is a second year hematology and oncology fellow at the Medical College of Wisconsin in Milwaukee, Wisconsin. His research and career interests include lymphoma, gastrointestinal oncology, and improving patient care using health informatics.

Andrew G. Volk, PhD


Andrew Volk, PhD

Dr. Volk received his PhD in molecular biology of stem cell development at Loyola University in Chicago, Illinois. He is a current postdoctoral fellow with John Crispino at Northwestern University, and is currently supported by an ASH Scholar Award for Basic/Translational Research. He studies how the histone chaperone CHAF1B contributes to hematopoietic stem cell function and leukemogenesis.

back to top